Once-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients With Narcolepsy.
Clete A KushidaColin M ShapiroThomas RothMichael J ThorpyBruce C CorserAkinyemi O AjayiRussell RosenbergAsim RoyDavid SeidenJordan DubowYves DauvilliersPublished in: Sleep (2021)
ON-SXB significantly improved narcolepsy symptoms; its safety profile was consistent with SXB. ON-SXB conferred efficacy with a clearly beneficial single nighttime dose.